Viatris (VTRS) Receivables (2019 - 2026)
Viatris (VTRS) recorded quarterly Receivables of $3.6 billion in Q1 2026, up 2.59% quarter-over-quarter from $3.5 billion in Q4 2025, and up 14.38% on a YoY basis from $3.1 billion in Q1 2025.
Viatris (VTRS) Receivables (2019 - 2026) Analysis & Trends
Viatris' Receivables history runs 8 years deep, the most recent figure standing at $3.6 billion for Q1 2026.
- In Q1 2026, Receivables rose 14.38% year-over-year to $3.6 billion; the TTM figure through Mar 2026 stood at $3.6 billion (up 14.38% YoY), while the FY2025 annual figure was $3.5 billion, down 7.49% from the prior year.
- Receivables was $3.6 billion for Q1 2026 at Viatris, up from $3.5 billion in the prior quarter.
- In the past five years, Receivables ranged from a high of $4.6 billion in Q1 2022 to a low of $3.1 billion in Q1 2025.
- Historically, Receivables has averaged $4.0 billion across 5 years, with a median of $4.0 billion in 2023.
- The sharpest annual moves came in 2022 and 2023: Receivables plunged 31.25% in 2022, then advanced 27.36% in 2023.
- A 5-year view of Receivables shows it stood at $4.4 billion in 2022, then gained by 4.37% to $4.6 billion in 2023, then declined by 17.69% to $3.8 billion in 2024, then declined by 7.49% to $3.5 billion in 2025, then rose by 2.59% to $3.6 billion in 2026.
- The last three Receivables figures came in at $3.6 billion (Q1 2026), $3.5 billion (Q4 2025), and $3.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.39 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.51 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 312.00 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 31.29 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 768.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.15 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 407.63 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 355.67 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 149.62 Mn |
| 10 | Viatris | - | - | 1.16 Bn | 3.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.58 Bn |
| Dec 31, 2025 | 3.49 Bn |
| Sep 30, 2025 | 3.83 Bn |
| Jun 30, 2025 | 3.72 Bn |
| Mar 31, 2025 | 3.13 Bn |
| Dec 31, 2024 | 3.77 Bn |
| Sep 30, 2024 | 3.72 Bn |
| Jun 30, 2024 | 4.45 Bn |
| Mar 31, 2024 | 4.47 Bn |
| Dec 31, 2023 | 4.58 Bn |
| Sep 30, 2023 | 4.25 Bn |
| Jun 30, 2023 | 4.09 Bn |
| Mar 31, 2023 | 3.97 Bn |
| Dec 31, 2022 | 4.39 Bn |
| Sep 30, 2022 | 3.33 Bn |
| Jun 30, 2022 | 4.29 Bn |
| Mar 31, 2022 | 4.63 Bn |
| Dec 31, 2021 | 4.76 Bn |
| Sep 30, 2021 | 4.85 Bn |
| Jun 30, 2021 | 4.48 Bn |